1688P Impact of immunotherapy on the risk of thromboembolic disease in patients with melanoma

Autor:	J. Rubio Pérez, M. Lobo de Mena, A. Muñoz Martín, A.M. Martin Fernandez de Soignie, T. Quintanar Verduguez, N. Blaya Boluda, D. Fernandez Garay, A.B. Ruperez Blanco, J.Z. Benoit-Perejón, L. Jiménez Colomo, M.C. Rosa Garrido, C. Guirao Rubio, C. Font Puig, M. Sánchez Cánovas, B. Obispo Portero, J. Bosque Moreno, L. Ortega Morán
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty business.industry Melanoma medicine.medical_treatment Hematology Immunotherapy medicine.disease Internal medicine medicine Thromboembolic disease In patient business
Zdroj:	Annals of Oncology. 32:S1181
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.1660
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4d6460b98c876f3159c6c985d7b8012d https://doi.org/10.1016/j.annonc.2021.08.1660 Zobrazit plný text záznamu